CSF copper concentration: a new parameter for diagnosis and monitoring therapy of Wilson's disease with cerebral manifestation
- 1 June 1987
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 79 (1-2) , 229-237
- https://doi.org/10.1016/0022-510x(87)90275-9
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Effective treatment of Wilson's disease with oral zinc sulphate: two case reports.BMJ, 1984
- Wilson's disease: Visual evoked responses in correlation with the clinical courseElectroencephalography and Clinical Neurophysiology, 1983
- Nuclear Magnetic Resonance (NMR) Imaging in Wilson DiseaseJournal of Computer Assisted Tomography, 1983
- TREATMENT OF WILSON'S DISEASE WITH TRIENTINE (TRIETHYLENE TETRAMINE) DIHYDROCHLORIDEThe Lancet, 1982
- Brainstem auditory evoked responses in spinocerebellar engeneration and wilson diseaseAnnals of Neurology, 1981
- Disappearance of Kayser-Fleischer Rings After Liver TransplantationArchives of Ophthalmology (1950), 1979
- Antigen-antibody crossed electrophoresisAnalytical Biochemistry, 1965
- DETERMINATION OF COPPER IN CEREBROSPINAL FLUID BY ACTIVATION ANALYSISJournal of Neurochemistry, 1963
- WILSON'S DISEASE: NEW ORAL THERAPYThe Lancet, 1956
- Studies on Copper Metabolism. XIII. Hepatolenticular Degeneration1Journal of Clinical Investigation, 1954